Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price
Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....
594 Views
Smartkarma’s Week that Was in JP/KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split
Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...
438 Views
Stub Trade on Samsung C&T with BioLogics as a Sole Pair Partner
The last Samsung C&T (028260 KS) block deals ended last month on Sep 20. C&T is now free of circular shareholding links. That is, C&T...
617 Views
Celltrion: Understanding Inflectra's U.S. Challenges
Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...
754 Views
Samsung C&T Placement: Finally First Step Towards a Legit Holding Company
I would take this deal. I believe the market will interpret this placement as the starting point of C&T-centered holding company conversion....
627 Views